cuprizone has been researched along with Schizophrenia in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 16 (72.73) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gu, LH; Li, L; Ma, DL; Sun, ZY; Zhang, L | 1 |
| Liu, JC; Liu, L; Ma, QR; Peng, ZW; Qin, JH; Tan, QR; Wang, HN; Xue, F; Xue, SS; Zhou, CH | 1 |
| Gu, LH; Li, L; Li, XM; Ma, DL; Sun, ZY; Wang, MY; Yang, CC; Zhang, JW; Zhang, L | 1 |
| Ai, H; Chang, H; Chen, G; Liu, J; Wang, F; Wu, Y; Yin, L; Zhang, L; Zhang, Y | 1 |
| Fang, M; Liu, H; Wang, B; Zhai, J | 1 |
| Fang, Z; Huang, Q; Kong, J; Xu, H; Yang, L; Zhang, J | 1 |
| Adilijiang, A; He, J; Li, X; Lin, D; Wang, W; Xu, Z; You, P | 1 |
| Chang, H; Chen, Y; Cong, H; Du, L; Geng, X; Wei, Y; Yin, L; Zhang, X | 1 |
| Fujimura, Y; Hayakawa, E; Kanba, S; Kato, TA; Miura, D; Ohgidani, M | 1 |
| Tezuka, T | 1 |
| Adilijiang, A; Hartle, K; Huang, Q; Kong, J; Li, XM; Tan, Q; Wang, J; Wang, L; Xu, H; Zhang, D; Zhang, H; Zhang, Y; Zhang, Z | 1 |
| Peng, H; Wu, R; Xu, H; Xuan, Y; Yan, G | 1 |
| Codagnone, M; Pasquini, JM; Reinés, A; Rosato Siri, MV; Valeiras, B | 1 |
| Fukunari, A; Kajii, Y; Kondo, MA; Okada, K; Sakaue, M; Takemoto, K; Tamura, M; Tezuka, T; Yasumatsu, H | 1 |
| Dai, Z; Shen, Z; Wu, R; Xu, H; Xuan, Y; Yan, G; Zhang, G | 1 |
| Chen, YC; Liu, GH; Peng, Y; Peng, ZW; Tan, QR; Wang, HN; Wu, D; Xue, F; Zhang, RG | 1 |
| Fan, S; He, Y; Li, Z; Sun, B | 1 |
| Auladell, C; Franco-Pons, N; Martorell, L; Roig, B; Tomàs, J; Vilella, E | 1 |
| Chew, LJ; Schmitz, T | 1 |
| Browning, R; Clough, RW; Li, XM; Wang, H; Xiao, L; Xu, H; Yang, HJ; Zhang, Y | 1 |
| Herring, NR; Konradi, C | 1 |
| Bi, X; He, J; Jiang, W; Kong, J; Li, XM; Tan, Q; Wang, J; Wang, L; Xiao, L; Xu, H; Zhang, D; Zhang, H; Zhang, R; Zhang, Y; Zhu, S | 1 |
3 review(s) available for cuprizone and Schizophrenia
| Article | Year |
|---|---|
[Cuprizone short-term exposure: glial activation and psychosis-like behavior].
Topics: Animals; Brain; Cuprizone; Cytokines; Disease Models, Animal; Drug Discovery; Encephalitis; Humans; Inflammation Mediators; Mice; Schizophrenia | 2013 |
Cytokines and myelination in the central nervous system.
Topics: Alzheimer Disease; Animals; Brain; Brain Ischemia; Central Nervous System; Cuprizone; Cytokines; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Humans; Hyperoxia; Infant, Newborn; Inflammation; Multiple Sclerosis; Myelin Sheath; Schizophrenia; Signal Transduction | 2008 |
Myelin, copper, and the cuprizone model of schizophrenia.
Topics: Animals; Biological Evolution; Copper; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Humans; Mice; Myelin Sheath; Oligodendroglia; Schizophrenia | 2011 |
19 other study(ies) available for cuprizone and Schizophrenia
| Article | Year |
|---|---|
DHF-7 Ameliorates Behavioral Disorders and White Matter Lesions by Regulating BDNF and Fyn in a Mouse Model of Schizophrenia Induced by Cuprizone and MK-801.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cuprizone; Disease Models, Animal; Dizocilpine Maleate; Humans; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-fyn; Schizophrenia; White Matter | 2022 |
The impact of quetiapine on the brain lipidome in a cuprizone-induced mouse model of schizophrenia.
Topics: Animals; Brain; Cognition; Cuprizone; Disease Models, Animal; Lipidomics; Male; Mice; Mice, Inbred C57BL; Quetiapine Fumarate; Schizophrenia | 2020 |
Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801.
Topics: Animals; Anxiety; Behavior, Animal; Chelating Agents; Corpus Callosum; Cuprizone; Dizocilpine Maleate; Hyperkinesis; Injections, Intraperitoneal; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology; Spatial Memory; White Matter | 2021 |
Increased central dopaminergic activity might be involved in the behavioral abnormality of cuprizone exposure mice.
Topics: Animals; Astrocytes; Behavior, Animal; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Dopamine; Male; Memory, Short-Term; Mice, Inbred C57BL; Microglia; Oligodendroglia; Schizophrenia | 2017 |
Olig2 Silence Ameliorates Cuprizone-Induced Schizophrenia-Like Symptoms in Mice.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Cuprizone; Disease Models, Animal; Glial Fibrillary Acidic Protein; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin Sheath; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Schizophrenia; Up-Regulation | 2017 |
Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain.
Topics: Adenosine; Animals; Behavior, Animal; Brain Chemistry; Cerebral Cortex; Chelating Agents; Cuprizone; Cytokines; Demyelinating Diseases; Dose-Response Relationship, Drug; Gliosis; Hippocampus; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Oligodendroglia; Psychomotor Performance; Schizophrenia | 2018 |
Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia.
Topics: Animals; Arecoline; Chelating Agents; Cholinergic Agonists; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Schizophrenia | 2019 |
The antipsychotic-like effects of clozapine in C57BL/6 mice exposed to cuprizone: Decreased glial activation.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Cuprizone; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neuroglia; Schizophrenia | 2019 |
Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus.
Topics: Animals; Cuprizone; Disease Models, Animal; gamma-Aminobutyric Acid; Glycine; Hippocampus; Male; Metabolomics; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Schizophrenia; Serine | 2019 |
Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
Topics: Animals; Antipsychotic Agents; Astrocytes; Benzodiazepines; Cuprizone; Demyelinating Diseases; Female; Frontal Lobe; Insulin-Like Growth Factor I; Mice; Mice, Inbred C57BL; Microglia; Myelin Sheath; Olanzapine; Oligodendroglia; Schizophrenia; Stem Cells | 2014 |
Concurrent changes in ¹H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: possible implications for schizophrenia.
Topics: Animals; Antioxidants; Brain; Chelating Agents; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Hydrogen Peroxide; Male; Mice, Inbred C57BL; Oligodendroglia; Schizophrenia | 2014 |
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Topics: Animals; Astrocytes; Brain; Cuprizone; Demyelinating Diseases; Diet; Disease Models, Animal; Dopamine; Female; Male; Microglia; Motor Activity; Rats, Wistar; Recognition, Psychology; Schizophrenia; Serotonin; Sex Characteristics; Social Behavior; Tyrosine 3-Monooxygenase | 2014 |
[Cuprizone early deficits accompanied by specific glial activation implicate pathophysiological changes in schizophrenia].
Topics: Animals; Behavior, Animal; Cuprizone; Male; Mice; Mice, Inbred C57BL; Neuroglia; Organ Specificity; Schizophrenia | 2013 |
Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks: potential implications for schizophrenia.
Topics: Animals; Anxiety; Behavior, Animal; Brain Chemistry; Chelating Agents; Cognition; Cuprizone; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred C57BL; Motor Activity; Schizophrenia | 2015 |
Quetiapine Ameliorates Schizophrenia-Like Behaviors and Protects Myelin Integrity in Cuprizone Intoxicated Mice: The Involvement of Notch Signaling Pathway.
Topics: Animals; Cuprizone; Demyelinating Diseases; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Myelin Sheath; Neuroprotective Agents; Peptides; Quetiapine Fumarate; Receptors, Notch; Schizophrenia; Signal Transduction | 2015 |
Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination.
Topics: Animals; Behavior, Animal; Brain; Cell Differentiation; Clemastine; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Exploratory Behavior; Male; Mice; Mice, Inbred C57BL; Motor Activity; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Schizophrenia | 2015 |
Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro.
Topics: Animals; Cell Differentiation; Cell Line; Corpus Callosum; Cuprizone; Discoidin Domain Receptors; Humans; Male; Mice; Models, Animal; Monoamine Oxidase Inhibitors; Myelin Proteins; Myelin Sheath; Oligodendroglia; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; RNA, Messenger; Schizophrenia; Up-Regulation | 2009 |
Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.
Topics: Animal Feed; Animals; Behavior, Animal; Body Weight; Chelating Agents; Copper; Cuprizone; Demyelinating Diseases; Male; Mice; Mice, Inbred C57BL; Myelin Sheath; Nerve Fibers, Myelinated; Neuropil; Oligodendroglia; Prosencephalon; Schizophrenia | 2009 |
Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination.
Topics: Animals; Antipsychotic Agents; Chelating Agents; Cuprizone; Demyelinating Diseases; Dibenzothiazepines; Disease Models, Animal; Memory, Short-Term; Mice; Mice, Inbred C57BL; Motor Activity; Myelin Sheath; Oligodendroglia; Quetiapine Fumarate; Regeneration; Schizophrenia | 2012 |